Victoza (active ingredient liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication manufactured by Novo ...

The hidden cost GLP boom shows total payments rose sharply from 2017-2022 despite lower out-of-pocket costs, impacting insurers and Medicare programs.

This Kansas City, Kansas, advocate calls for Congress to cap out-of-pocket costs at $35 a month. | Opinion ...

A routine medical examination delivered a life-altering diagnosis that would cost one young labourer his sight, his health ...

Diabetes care is changing. New guidelines emphasize that managing emotional distress is just as vital as tracking your ...

Dallas expected to save $12 million on employee healthcare this year, but rising GLP-1 drug use and high-cost claims now have ...

Now, a group of U.S. Senators is pushing legislation that would cap what many privately insured patients pay for insulin at ...

By Nqobile Dludla JOHANNESBURG, July 17 (Reuters) - Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering with healthcare ...

Employers are bracing for what could be the highest rise in health insurance premiums in 16 years, driving up the cost of ...

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new ...

If you have diabetes, your health care provider may recommend Trulicity or Mounjaro, two medications approved by the U.S.

About a dozen states offer "medically tailored meals" to people with conditions such as diabetes and heart disease who get ...